
○ September 15: ACQR Retreat, DoubleTree hotel in Ann Arbor, MI
○ October 13: MPOG Retreat in San Francisco, CA
○ May 24th 1pm EST: Obstetric Subcommittee Meeting
○ June 26, 4pm EST: Pediatric Subcommittee Meeting
5. Measure Selection Tool Pilot
○ New Measure Selection Application released to allow sites to update the measures included in
provider feedback emails & individual provider dashboards. Pilot phase only (Michigan sites) for
this month, will launch to all sites next month if pilot goes well
6. New Measures Released!:
○ GA-03-OB: Cesarean Delivery Cases where general anesthesia was administered after epidural
analgesia
○ GLU-06-CARD: Patients ≥18 years age & undergoing an open cardiac procedure requiring general
anesthesia, for whom any intraoperative blood glucose value did not exceed 180 mg/dL.
7. Measure Review: GLU-01/GLU-03/GLU-05: Hyperglycemia Management, Patrick Henson, MD -
Vanderbilt University
○ DISCUSSION:
■ See presentation slides for additional literature included as part of Dr. Henson’s review.
■ Dr. Henson’s Recommendations:
● Recommendation to retire GLU 01 due to reduced relevance.
● GLU 03: Redefine to recheck only & modify threshold to >180 rather than 200 mg/dL
● GLU 05: Modify threshold to >180 rather than 200 mg/dL per recent literature and
societal recommendations
■ Xan Abess (Dartmouth): Reasonable to go to 180 mg/dL; still some value in having separate
measures for GLU 01, GLU 03, and GLU 05 to allow for phasing in improvement locally. We
started with GLU 01 first to address intraop issues and then progressed to the perioperative
period
■ Guarav Katta (HF Allegiance): What is the rationale for retiring GLU 01 again?
● Patrick Henson (Vanderbilt): If I could only have one reported to me for my own practice,
I would think GLU 03 would be sufficient. To reduce overlap and redundancy of
measures.
● Gaurav Katta (HF Allegiance): I actually like the break out of the intraop vs. the periop
flagged cases for the separate measures but I do think we should update the threshold
to 180 mg/dL to align with evidence based recommendations.
■ Pam Tyler (Corewell East): Just a reminder that GLU 03 is a P4P measure for Michigan sites so
any change could impact this.
● Nirav Shah (MPOG Quality Director): We have a couple of options for how to deploy
this…we could replicate the measure and have a secondary measure for 180 mg/dL for
a period of time (similar to how we published PUL 02 after PUL 01) or we can modify the
existing measure
■ Patrick Henson (Vanderbilt): What about the modification to update GLU 03 to be a recheck
only measure?
● Nirav Shah (MPOG Quality Director): I think we have options for how to deploy this
change as well and would likely need to roll out a separate measure for recheck only